Siga Resources Inc (SGAE)

Gold’s combination of high conductivity and resistance to corrosion has made the precious metal popular in electronic applications. The main use of gold in electronics has been with the plating of contacts in switches, relays, and connectors. Another of gold’s uses has been in electrical wiring for high-energy applications. This was done for several of the Manhattan Project’s atomic experiments.
Gold is still popular for use in sliding style electrical contacts, especially where corrosion or very high humidity are factors. Another type of contact, a switch contact, also uses gold regularly.

Siga Resources Inc, founded in 2007, is based in South Lake Tahoe, California. Siga is a mineral resource exploration and development company. Siga’s strategy targets properties that have the potential for near term production and early positive cash flow. Siga’s general geographical interest is North and South America.

Siga Resources, Inc. announced that Siga has come to an agreement with Big Rock Resources Ltd. whereby the two companies will develop the Lucky Thirteen gold placer claim under a 50/50 joint venture.

Big Rock Resources Ltd. (1BR.F, ISIN CA0894851066, WKN A1JJYB www.bigrockresources.com) has agreed to fund the initial evaluation program for $400,000 USD, and provide funding up to $8.5 million USD to place the property in full production.

The partners will operate Lucky Thirteen under a Joint Venture company, Lucky 13 Mining Company Ltd., owned 50/50 by Siga and Big Rock. Lucky 13 Mining Company Ltd. will be the operator.

Siga has already secured the initial operating permits for the necessary rail crossing and initial test mining. Siga is currently constructing the washing and initial process plant to be used in the evaluation program.

Siga’s President Ed Morrow said that “Siga is most pleased to have Big Rock Resources as a Joint Venture Partner. The combined power of the partnership will facilitate the rapid development of a production operation at Lucky thirteen.”

For more information about Siga Resources, Inc. by going through its website at http://sigaresourcesinc.com

*************************************************************

Power3 Medical Products Inc. (PWRM)

Parkinson’s disease causes problems in the nerve cells in the brain that control muscle movement. Nerve cells that make a chemical called dopamine normally send signals that help coordinate your movements. In people who have Parkinson’s disease, these cells die or do not work properly.

People who have Parkinson’s disease experience tremors or shaking as a result of the damage to their nerve cells. Tremors caused by Parkinson’s get worse when the person is at rest and better when the person moves. The tremor may affect one side of the body more than the other, and can affect the lower jaw, arms and legs. Handwriting may also look “shaky” and smaller than usual. Other symptoms of Parkinson’s disease include nightmares, depression, and extra saliva, difficulty walking or buttoning clothes, or cutting food.

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease). Power3 Medical applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual’s proteins to detect the presence of disease, a patient’s disease progression, a patient’s response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.

The NuroPro Blood Test of Power3 Medical Products, Inc is a diagnostic tool for the early detection of Neurodegenerative diseases. The analysis is designed as a tool for physicians to diagnose various degenerative diseases of the brain and nervous system. The test involves monitoring the concentration of 59 proteins in blood serum to accurately detect and distinguish between Alzheimer’s disease, ALS (Lou Gehrig’s disease), and Parkinson’s disease. Early detection of these diseases would allow physicians to intervene at an early stage to delay disease progression, potentially allowing patients to outlive their debilitating symptoms.

For more information about Power3 Medical Products, Inc., please visit http://www.power3medical.com

**********************************************************

American Eagle Outfitters, Inc. (NYSE:AEO) announced earnings for the first quarter ended April 30, 2011 of $0.14 per diluted share, compared to income from continuing operations of $0.17 per diluted share last year. First Quarter Results - Continuing Operations: Total sales for the quarter decreased 6% to $610 million, compared to $648 million last year. First quarter comparable store sales decreased 8%, compared to a 5% increase last year.Gross profit was $232 million, or 38.0% as a rate to sales, compared to $258 million, or 39.7% as a rate to sales, last year. The merchandise margin increased 70 basis points. As a rate to sales, buying, occupancy and warehousing costs increased 240 basis points. Selling, general and administrative expense decreased 6% to $158 million, compared to $169 million last year. As a rate to sales, SG&A was flat to last year at 26.0%.

American Eagle Outfitters, Inc. operates as an apparel and accessories retailer in the United States and Canada.

**********************************************************

Renren Inc. American Depositary (NYSE:RENN) announced that it will report its first quarter 2011 unaudited financial results on Monday, June 20, 2011, after the close of the U.S. markets. The earnings teleconference call with simultaneous webcast will take place at 8:00 p.m. Eastern Time on Monday, June 20, 2011 (Beijing/Hong Kong Time: 8:00 a.m., Tuesday, June 21, 2011). Renren’s management will be on the call to discuss the quarterly results and answer questions.

Renren Inc. operates a social networking Internet platform in China. Its platform enables users to connect and communicate with each other; share information and user-generated content; play online games; listen to music; and shop for deals.

**********************************************************

Delaware Enhanced Global Divide (NYSE:DEX) the Board of Directors of Delaware Investments Global Dividend and Income Fund, Inc. (NYSE:DGF) (”DGF”) and the Board of Trustees of Delaware Enhanced Global Dividend and Income Fund (NYSE:DEX) (”DEX”) announced their decision to approve a proposal providing for the reorganization of DGF into DEX. Under the terms of the proposed reorganization, DEX would acquire substantially all of DGF’s assets in exchange for newly issued shares of common beneficial interest of DEX.

Those shares of DEX would then be distributed pro rata to DGF’s shareholders, and DGF would subsequently be liquidated and dissolved. Common shares of DGF would be exchanged for common shares of DEX based on the relative net asset values of each Fund’s common shares. These transactions, which are expected to be tax-free, are subject to the approval of the Agreement and Plan of Acquisition by each Fund’s shareholders.

**************************************************************

**************************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) has received 2,000,000 shares of (144) restricted common stock from the company and anticipates receiving 2,500,000 shares of free trading shares from a third party for six months of media advertisement and IR services for SIGA Resources, Inc. (SGAE.OB).
Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).

Suntech Power Holdings Co. Ltd. (NYSE:STP), the world’s largest producer of solar panels, has engaged a third production shift at its new solar panel manufacturing facility in Goodyear, Arizona. The expansion adds another 30 solar jobs to Arizona’s fast-growing solar economy. The state-of-the-art module manufacturing facility will now run twenty-four hours per day with 107 employees. The new group of employees completed training on May 13th, after weeks working side-by-side with the facility’s existing first and second production shifts. The expansion brings the facility’s annualized production throughput to about 50MW, representing 15,000 high-quality solar panels per month.

Suntech Power Holdings Co., Ltd., a solar energy company, engages in the design, development, manufacture, and marketing of photovoltaic (PV) products.

****************************************************

Siga Resources Inc (SGAE)

Gold is a soft, shiny, and malleable precious metal that has a bright yellow color. In fact, gold is the most malleable of all metals. Unlike other metals, gold does not oxidize with air or water and maintains its color and luster. Gold is highly conductive to electricity so it is often used to make electrical wiring in high energy applications. It is also used to make a thin layer coating on a variety of electronic connectors because of its resistance to corrosion and oxidization. For example, gold is used in connectors of audio, video, and USB cables. In addition, fine gold wires are used to connect semiconductor devices to their packages.

Other industry uses of gold include making thread for embroidery, special reflective layers on expensive CDs, and insulation for automobiles. In photography, gold toners are used to alter the color of prints. Gold is used to make a protective coating on many artificial satellites because it is a good reflector of electromagnetic radiation. It is also used to make thermal protective faceplates for astronauts.

Siga Resources Inc, founded in 2007, is based in South Lake Tahoe, California. Siga is a mineral resource exploration and development company. Siga’s strategy targets properties that have the potential for near term production and early positive cash flow. Siga’s general geographical interest is North and South America.

Siga Resources, Inc. announced that Siga has come to an agreement with Big Rock Resources Ltd. whereby the two companies will develop the Lucky Thirteen gold placer claim under a 50/50 joint venture.

Big Rock Resources Ltd. (1BR.F, ISIN CA0894851066, WKN A1JJYB www.bigrockresources.com) has agreed to fund the initial evaluation program for $400,000 USD, and provide funding up to $8.5 million USD to place the property in full production.

The partners will operate Lucky Thirteen under a Joint Venture company, Lucky 13 Mining Company Ltd., owned 50/50 by Siga and Big Rock. Lucky 13 Mining Company Ltd. will be the operator.

Siga has already secured the initial operating permits for the necessary rail crossing and initial test mining. Siga is currently constructing the washing and initial process plant to be used in the evaluation program.

Siga’s President Ed Morrow said that “Siga is most pleased to have Big Rock Resources as a Joint Venture Partner. The combined power of the partnership will facilitate the rapid development of a production operation at Lucky thirteen.”

For more information about Siga Resources, Inc. by going through its website at http://sigaresourcesinc.com

***********************************************************

Power 3 Medical Products Inc. (PWRM)

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease). Power3 Medical applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer’s, Parkinson’s, and ALS diseases, for which it is currently engaged in Phase II clinical trials. These tests are designed to analyze an individual’s proteins to detect the presence of disease, a patient’s disease progression, a patient’s response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.

Parkinson’s disease occurs when certain nerve cells, or neurons, in an area of the brain known as the substantia nigra die or become impaired. Normally, these neurons produce an important brain chemical known as dopamine. Dopamine is a chemical messenger responsible for transmitting signals between the substantia nigra and the next “relay station” of the brain, the corpus striatum, to produce smooth, purposeful muscle activity. Loss of dopamine causes the nerve cells of the striatum to fire out of control, leaving patients unable to direct or control their movements in a normal manner. Studies have shown that Parkinson’s patients have a loss of 80 percent or more of dopamine-producing cells in the substantia nigra. The cause of this cell death or impairment is not known but significant findings by research scientists continue to yield fascinating new clues to the disease.

The NuroPro Blood Test of Power3 Medical Products, Inc is a diagnostic tool for the early detection of Neurodegenerative diseases. The analysis is designed as a tool for physicians to diagnose various degenerative diseases of the brain and nervous system. The test involves monitoring the concentration of 59 proteins in blood serum to accurately detect and distinguish between Alzheimer’s disease, ALS (Lou Gehrig’s disease), and Parkinson’s disease. Early detection of these diseases would allow physicians to intervene at an early stage to delay disease progression, potentially allowing patients to outlive their debilitating symptoms.

For more information about Power3 Medical Products, Inc., please visit http://www.power3medical.com

****************************************************

MF Global Holdings Ltd. (NYSE:MF) disclosed it has granted and priced an inducement stock option award to Richard Moore, managing director of Europe, in accordance with the terms of his employment agreement. The inducement award granted to Mr. Moore is a stock option to purchase 1.0 million shares of MF Global common stock at an exercise price per share of $7.45. One third of the options will vest on each anniversary of the grant date, with all the options becoming fully vested on the third anniversary of the grant date. Once vested, the option will generally remain exercisable for the full seven-year term. In the event Mr. Moore is terminated “without cause,” he shall be permitted to exercise the portion of his stock option that had already vested as of the date of his termination for one year after his termination date.

MF Global Holdings Ltd., together with its subsidiaries, operates as a brokerage firm offering customized solutions in global cash and derivatives markets.

****************************************************

Eaton Vance Senior Income Trust (NYSE:EVF) the Trustees of Eaton Vance Floating-Rate Income Trust (NYSE:EFT), Eaton Vance Senior Floating-Rate Trust (NYSE:EFR) and Eaton Vance Senior Income Trust (NYSE:EVF), each a diversified closed-end investment company (together the “Funds”), have approved a change to the Funds’ investment policies to expand the “Authorized Foreign Currencies” in which the Funds may invest to include Australian dollars.

Eaton Vance Senior Income Trust is a closed-ended fixed income mutual fund launched and managed by Eaton Vance Management. The fund invests in the fixed income markets of the United States.

**************************************************************

**************************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) has received 2,000,000 shares of (144) restricted common stock from the company and anticipates receiving 2,500,000 shares of free trading shares from a third party for six months of media advertisement and IR services for SIGA Resources, Inc. (SGAE.OB).
Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).

SWS Group Inc. (NYSE:SWS) announced that at the Company’s special meeting of stockholders held May 18, 2011, SWS Group’s stockholders voted to approve the proposed $100 million capital raise with Hilltop Holdings Inc. (NYSE:HTH) and Oak Hill Capital Partners. “On behalf of the Board of Directors and management team, I want to thank our stockholders, customers and dedicated employees for their support throughout this process. We look forward to completing this transaction as soon as possible and continuing to meet the needs of our customers for many years to come.” said James H. Ross, Chief Executive Officer of SWS Group.

SWS Group, Inc., through its subsidiaries, provides various financial services in the United States. The company operates in four segments: Clearing, Retail, Institutional, and Banking.

***************************************************

Power 3 Medical Products Inc. (PWRM)

Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease). Power3 Medical applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, Power3 Medical has developed a portfolio of products including BC-SeraPro.

The exact cause of breast cancer is unknown. Factors that can increase a woman’s risk include heredity, early puberty, late childbearing, obesity, and lifestyle factors such as heavy alcohol consumption and smoking. The biggest risk factor for breast cancer is age just growing older. Most breast cancers occur in women over the age of 50, and women over 60 are at the highest risk.

A woman’s risk for developing breast cancer increases if her mother, sister, daughter, or two or more other close relatives, such as cousins, have a history of breast cancer, especially at a young age. However, 85% of women who develop breast cancer have NO known family history of the disease.

BC-SeraPro™ is a proteomic test for the diagnosis of breast cancer. This test is designed to measure the quantitative expression level of 22 protein biomarkers in the serum that differentiate between breast cancer patients and control subjects. The level of the biomarkers from the patient’s serum sample is compared to the Power3 Medical Products’ patient database. Statistical analysis by linear discriminant function will analyze the biomarker levels of the patient sample and assign a probability score for the diagnosis of the patient sample. Probability score is ranged from 0.0 to 1.0. Results of the BC-SeraPro™ test should not be considered a standalone diagnosis nor a guarantee and is intended to be used in conjunction with mammography and other accepted modalities.

For more information about Power3 Medical Products, Inc., please visit http://www.power3medical.com

**************************************************

Cleantech Transit, Inc. (CLNO)

Cleantech Transit, Inc. is in the business of producing and conserving power. They produce and sell clean electricity globally, with a focus on sustainable energies using renewable resources such as Geothermal, Solar and Wind. Cleantech Transit, Inc goal is to use innovative technologies to reduce electricity consumption and dependence on carbon based energy.

Cleantech Transit Inc. was founded to capitalize on technology advances and manufacturing opportunities in the growing clean energy public transportation sector. The Company has expanded its focus to invest directly in specific green projects. Recognizing the many economic and operational advances of converting wood waste into renewable sources of energy, Cleantech has selected to invest in Phoenix Energy (www.phoenixenergy.net). This project could benefit the Company’s manufacturing clients worldwide.

Biomass can be used for direct heating (such as burning wood in a fireplace or wood stove), for generating electricity, or can be converted directly into liquid fuels to meet transportation energy needs.
Biomass power is close to a carbon-neutral electric power generation option. Biomass absorbs carbon dioxide from the atmosphere during its growth and then emits an equal amount of carbon dioxide when it is processed to generate electricity. Thus, biomass fuels “recycle” atmospheric carbon, and may reduce global warming impacts. Biopower facilities produce fewer other pollutants than equivalent fossil fuel power facilities.

Cleantech Transit Inc. recently announced that funding to be provided to Phoenix Energy for the commercialization of a 500 Kilowatt biomass gasification plant should be eligible to apply for a renewable energy cash back incentive program offered by the U.S. Federal Government. Once the final interconnect process and applications are complete the grant should be received within 60 days. The 5-year grant vesting period, means all parties must remain owner of record for that length of time, underscoring Cleantech and its partners’ commitment to this project and the host community. The U.S. Treasury’s cash grant program was created to provide funding, in lieu of tax credits, for the development of clean energy projects and clean tech jobs nationwide.
The Merced facility has already employed several individuals, both for the construction phase and subsequent plant operations once in service. As Company announced, the full commercial operation of the first plant is expected to be completed during the second quarter of 2011.

For more information about Cleantech Transit, Inc. visit its website www.cleantechtransitinc.com

***************************************************

LDK Solar Co., Ltd. (NYSE:LDK) reiterated its guidance for the first quarter 2011 and the full year 2011. Additionally, the company announced that it will report financial results for the first quarter ended March 31, 2011 after the market closes on Tuesday, June 7, 2011. The company will host a corresponding conference call and live webcast at 5:00 p.m. Eastern Time (ET) the same day. For the first quarter of 2011, LDK Solar reiterates its guidance of revenue in the range of $745 to $755 million, wafer shipments of 625 to 635 megawatts (MW), module shipments of 109 MW to 114 MW, in-house polysilicon production of 2,450 MT to 2,470 MT, in-house cell production between 44 MW and 46 MW, and gross margin between 30.0% and 31.0%.

LDK Solar Co., Ltd., through its subsidiaries, engages in the design, development, manufacture, and marketing of photovoltaic products; and development of power plant projects.

***************************************************

Zuoan Fashion Limited (NYSE:ZA) announced its financial results for the first quarter ended March 31, 2011. First Quarter 2011 Financial Performance: Revenue for the first quarter was RMB211.5 million ($32.3 million), a 44.1% increase from RMB146.8 million ($22.4 million) in the same period last year, Cost of sales increased 44.1% to RMB123.6 million ($18.9 million) in the first quarter of 2011 from RMB85.8 million ($13.1 million) in the same quarter of 2010, primarily as a result of the increase in sales volume. Gross profit in the first quarter of 2011 increased 44.0% to RMB88.0 million ($13.4 million) from RMB61.1 million ($9.3 million).

Zuoan Fashion Limited, through its subsidiaries, engages in the manufacture, distribution, and retailing of men’s apparel.

**************************************************************

**************************************************************************

THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!

Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. DrStockPick.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold DrStockPick.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://drstockpick.com/disclaimer) .Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings, Inc. (CRWE.OB) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (CRWE.OB), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (CRWE.OB) advertises for a particular client, Crown Equity Holdings Inc. (CRWE.OB) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (CRWE.OB), if paid in stock, can and may sell those securities during the advertising period.Crown Equity Holdings Inc. (CRWE.OB) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (PWRM.OB).
Crown Equity Holdings Inc. (CRWE.OB) anticipates receiving 5,000,000 shares of 144 restricted stocks from the company for 12 months of media advertisement and IR services for Cleantech Transit, Inc. (CLNO.OB).